Filings
Finds words inside filing documents. Searching Oncotelic Therapeutics, Inc.'s filings · 39 documents indexed.
6 documents · 41 matches
-
OTLC Oncotelic Therapeutics, Inc. 10-K 2026-04-15
Item 1A. Risk Factors
material weakness will not occur in the future, or our material weaknesses would be rectified. Any failure to implement and maintain8 matches in this document -
OTLC Oncotelic Therapeutics, Inc. 10-Q 2026-08-13
Item 4. Controls and Procedures
material weakness is a deficiency, or a combination of deficiencies, in internal control over financial reporting such that there is a reasonable7 matches in this document -
OTLC Oncotelic Therapeutics, Inc. 10-Q 2026-05-14
Item 4. Controls and Procedures
material weakness is a deficiency, or a combination of deficiencies, in internal control over financial reporting such that there is a reasonable7 matches in this document -
OTLC Oncotelic Therapeutics, Inc. 10-Q 2025-11-17
Item 4. Controls and Procedures
material weakness is a deficiency, or a combination of deficiencies, in internal control over financial reporting such that there is a reasonable7 matches in this document -
OTLC Oncotelic Therapeutics, Inc. 10-Q 2025-08-13
Item 4. Controls and Procedures
material weakness is a deficiency, or a combination of deficiencies, in internal control over financial reporting such that there is a reasonable6 matches in this document -
OTLC Oncotelic Therapeutics, Inc. 10-Q 2025-05-15
Item 4. Controls and Procedures
material weakness is a deficiency, or a combination of deficiencies, in internal control over financial reporting such that there is a reasonable6 matches in this document
Page 1 of 1 · 6 documents